Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

ClinicalTrials.gov ID: NCT06065540

Public ClinicalTrials.gov record NCT06065540. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 6:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. in Doses 2.4/2.4 mg and 1.0/1.0 mg Once Weekly Versus Semaglutide 2.4 mg and 1.0 mg, Cagrilintide 2.4 mg and Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Metformin With or Without an SGLT2 Inhibitor

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two medicines called semaglutide and cagrilintide. CagriSema will be compared to the two medicines semaglutide and cagrilintide, when they are taken alone. CagriSema will also be compared to a "dummy" medicine without any active ingredient. The study will be done in participants who have type 2 diabetes. Participants will take the study medicine together with the current diabetes medicine (metformin with or without an SGLT2 inhibitor).

Study identification

NCT ID
NCT06065540
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
2,734 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 27, 2023 (Actual)
Primary completion
Nov 19, 2025 (Actual)
Completion
Jan 6, 2026 (Actual)
Last update posted
Jul 8, 2026

2023 – 2026

United States locations

U.S. sites
100
U.S. states
30
U.S. cities
82
Facility City State ZIP Site status
Synexus Clin Res-Birmingham Birmingham Alabama 35211 —
Univ of Alabama_Birmingham Birmingham Alabama 35294 —
Cahaba Research Pelham Alabama 35124 —
Velocity Clinical Research-Phoenix Phoenix Arizona 85006 —
Synexus Rsch /Cnt Phnx Med C Phoenix Arizona 85020 —
Arkansas Clinical Research Little Rock Arkansas 72205 —
Velocity Clinical Res-Banning Banning California 92220 —
Velocity Clin Res-Chula Vista Chula Vista California 91911 —
John Muir Physicians Network Concord California 94520 —
Headlands Research California, LLC Escondido California 92025 —
Velocity Clin Res Gardena Gardena California 90247 —
Velocity Clin Res San Diego La Mesa California 91942 —
Loma Linda Univ Hlth Cr Endo Loma Linda California 92354 —
Facey Medical Foundation Mission Hills California 91345 —
Desert Oasis Hlthcr Med Group Palm Springs California 92262 —
Velocity Clin Res- San Bern San Bernardino California 92408 —
Linda Vista Health Care Ctr San Diego California 92111 —
Velocity Clin Res Santa Ana Santa Ana California 92704 —
Premier Medical Center, Inc. Toluca Lake California 91602 —
Velocity Clin Res - Panorama Van Nuys California 91405 —
Optumcare Clinical Trials,LLC-Golden Colorado Springs Colorado 80906 —
Northeast Research Institute Jacksonville Florida 32204 —
Clinical Trial Services Corp Miami Florida 33144 —
Bioclinical Research Alliance Miami Florida 33155 —
New Horizon Research Center Miami Florida 33165 —
South Broward Research LLC Miramar Florida 33027 —
West Orange Endocrinology Ocoee Florida 34761 —
Optimal Research Sites Orange City Florida 32763 —
Advent Health-Res Inst Orlando Florida 32804 —
AdventHealth Diab Inst Orlando Florida 32804 —
Synexus Clin Res - Orlando Orlando Florida 32806 —
Oviedo Medical Research, LLC Oviedo Florida 32765 —
Hope Clin Res & Wellness Conyers Georgia 30094 —
East Coast Institute for Res Macon Georgia 31210 —
Urban Family Practice Assoc Marietta Georgia 30067 —
Endocrine Research Solutions, Inc. Roswell Georgia 30076 —
Endocrine Research Solutions Roswell Georgia 30076 —
Pacific Diabetes & Endo Ctr Honolulu Hawaii 96813 —
St. Luke's Health System Boise Idaho 83702 —
Solaris Clinical Research Meridian Idaho 83646 —
Cedar-Crosse Research Center Chicago Illinois 60607 —
Clinical Invest Special_Gurnee Gurnee Illinois 60031 —
Endeavor Health Skokie Illinois 60077 —
Evanston Premier Hlthcr Res Skokie Illinois 60077 —
Iowa Diabetes & Endo Res Ctr West Des Moines Iowa 50266 —
Alliance for Multispec Res Newton Kansas 67114 —
Cotton-O'Neil Diab & Endo Ctr Topeka Kansas 66606 —
Velocity Clin Res Lafayette Lafayette Louisiana 70508 —
BTC of New Bedford, LLC New Bedford Massachusetts 02740 —
Velocity Clin Res Gulfport Gulfport Mississippi 39503 —
Diabetes & Endo Specialists Inc Chesterfield Missouri 63017 —
Premier Research Inc. Trenton New Jersey 08611 —
Velocity Clin Res Albuquerque Albuquerque New Mexico 87107 —
AMC Community Endocrinology Albany New York 12203 —
Velocity Clin Res Syracuse East Syracuse New York 13057 —
Southgate Medical Group, LLP West Seneca New York 14224 —
Great Lakes Medical Research Westfield New York 14787 —
University of North Carolina Chapel Hill North Carolina 27514 —
PharmQuest Life Sciences LLC Greensboro North Carolina 27408 —
Carteret Medical Group Morehead City North Carolina 28557 —
Piedmont Healthcare/Research Statesville North Carolina 28625 —
Accellacare Wilmington North Carolina 28401 —
Synexus Clinical Research US, Inc Akron Ohio 44311 —
Centricity Research Columbus Ohio 43213 —
Alliance for Multispec Res Norman Oklahoma 73069 —
Clinical Res Collaborative Cumberland Rhode Island 02864 —
Velocity Clin Res Providence East Greenwich Rhode Island 02818 —
AnMed Health IMA Anderson South Carolina 29621 —
Synexus Clin Res US-Anderson Anderson South Carolina 29621 —
Velocity Clinical Res-Anderson Anderson South Carolina 29621 —
Velocity Clin Res Gaffney Gaffney South Carolina 29340 —
Hillcrest Clinical Research Simpsonville South Carolina 29681-1538 —
Spartanburg Medical Research Spartanburg South Carolina 29303 —
Velocity Clin Res Spartanburg Spartanburg South Carolina 29303 —
Holston Medical Group Pc Bristol Tennessee 37620-7352 —
Holston Medical Group Kingsport Tennessee 37660 —
Clinical Research Associates Nashville Tennessee 37203 —
Arlington Family Res. Ctr Inc Arlington Texas 76012-4637 —
Velocity Clin Res Austin Austin Texas 78759 —
UT Health University of Texas Bellaire Texas 77401 —
Velocity Clinical Res-Dallas Dallas Texas 75230 —
North Texas Endocrine Center Dallas Texas 75231 —
Synexus Clin Res Dallas Dallas Texas 75234 —
Cedar Health Research Dallas Texas 75251 —
JCCT- Juno NW Houston Houston Texas 77040 —
Synergy Groups Medical Houston Texas 77061 —
PlanIt Research, PLLC Houston Texas 77079 —
Medical Colleagues-Texas LLP Katy Texas 77450 —
Sante Clinical Research Kerrville Texas 78028 —
Discovery MM Services, INC Missouri Missouri City Texas 77459 —
AES San Antonio San Antonio Texas 78229 —
University of Texas San Antonio San Antonio Texas 78229 —
NE Clin Res of San Antonio San Antonio Texas 78233 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
DM Clin Rsrch/Fam Diag Clinic Tomball Texas 77375 —
Diabetes & Endo Treatment Spec Sandy City Utah 84093 —
Velocity Clin Res-Salt Lk City West Jordan Utah 84088 —
TPMG Clinical Research Newport News Virginia 23606 —
Rainier Clin Res Ctr Inc Renton Washington 98057 —
St. Vincent Hosp-Prevea Health Green Bay Wisconsin 54303 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 305 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06065540, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06065540 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →